Khan, Nasir, et al. “Prospective Evaluation of Atrial Fibrillation Risk in Type 2 Diabetes Comparing SGLT-2 Inhibitors and DPP-4 Inhibitors”. Indus Journal of Bioscience Research, vol. 3, no. 3, Mar. 2025, pp. 69-75, https://doi.org/10.70749/ijbr.v3i3.797.